Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$477K Sell
29,987
-1,735
-5% -$26.9K 0.01% 1027
2026
Q1
$428K Sell
31,722
-2,387
-7% -$33.4K 0.01% 1028
2025
Q4
$428K Buy
34,109
+1,663
+5% +$17.9K 0.01% 999
2025
Q3
$321K Buy
32,446
+292
+0.9% +$2.84K ﹤0.01% 1189
2025
Q2
$287K Buy
32,154
+11,990
+59% +$101K ﹤0.01% 1209
2025
Q1
$176K Sell
20,164
-7,190
-26% -$75.5K ﹤0.01% 1328
2024
Q4
$339K Sell
27,354
-7,829
-22% -$96.2K ﹤0.01% 1117
2024
Q3
$404K Buy
35,183
+6,228
+22% +$71.9K 0.01% 1019
2024
Q2
$307K Buy
+28,955
New +$320K 0.01% 1088

Other funds holding VTRS

Choreo LLC's VTRS Position: Q2 2026 in Review

Choreo LLC reduced its Viatris (VTRS) stake by 5.5% in Q2 2026, selling an estimated $26.9K and leaving 29,987 shares worth $477K. The position accounts for 0.01% of the portfolio, ranked #1027.

Choreo LLC first reported a position in VTRS in Q2 2024 and has held it in 9 quarters since. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Choreo LLC held 29,987 shares of Viatris worth $477K as of Q2 2026.
  • Choreo LLC sold 1,735 Viatris shares in Q2 2026, an estimated $26.9K.
  • Viatris made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #1027 holding.
  • Choreo LLC first reported a position in Viatris in Q2 2024 and has held it in 9 quarters since.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.